PD
BEAM icon

Point72 (DIFC)’s Beam Therapeutics BEAM Stock Holding History

Point72 (DIFC)’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,477
Closed -$285K – 1675
2024
Q4 		$285K Buy
+11,477
New +$293K 0.01% 793
2024
Q2 		– Sell
-18,622
Closed -$615K – 1469
2024
Q1 		$615K Buy
+18,622
New +$580K 0.02% 691

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Point72 (DIFC)'s BEAM Position: Q1 2025 in Review

Point72 (DIFC) sold out of Beam Therapeutics (BEAM) in Q1 2025, closing a stake of 11,477 shares — an estimated $285K sold.

Point72 (DIFC) first reported a position in BEAM in Q1 2024 and held it in 2 quarters. The position peaked at $615K in Q1 2024. 238 funds tracked by Wall St. Rank hold BEAM as of Q1 2025.

  • Point72 (DIFC) reported no remaining Beam Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 11,477 Beam Therapeutics shares in Q1 2025, an estimated $285K.
  • Point72 (DIFC) first reported a position in Beam Therapeutics in Q1 2024 and held it in 2 quarters.
  • Point72 (DIFC)'s Beam Therapeutics position peaked at $615K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2025.

Based on Point72 (DIFC)'s 13F filing for Q1 2025, filed 15 May 2025.